S&P 500   4,585.59 (+0.80%)
DOW   36,117.38 (+0.17%)
QQQ   390.43 (+1.40%)
AAPL   194.27 (+1.01%)
MSFT   370.95 (+0.58%)
META   326.59 (+2.88%)
GOOGL   136.93 (+5.31%)
AMZN   146.88 (+1.63%)
TSLA   242.64 (+1.37%)
NVDA   465.96 (+2.40%)
NIO   7.49 (-3.35%)
BABA   72.33 (+1.17%)
AMD   128.37 (+9.89%)
T   17.09 (+0.89%)
F   10.82 (+1.22%)
MU   73.65 (+0.71%)
CGC   0.72 (+3.57%)
GE   119.48 (-0.28%)
DIS   92.35 (+0.93%)
AMC   6.82 (+0.44%)
PFE   28.63 (-0.56%)
PYPL   58.48 (-1.76%)
XOM   98.42 (-0.70%)
S&P 500   4,585.59 (+0.80%)
DOW   36,117.38 (+0.17%)
QQQ   390.43 (+1.40%)
AAPL   194.27 (+1.01%)
MSFT   370.95 (+0.58%)
META   326.59 (+2.88%)
GOOGL   136.93 (+5.31%)
AMZN   146.88 (+1.63%)
TSLA   242.64 (+1.37%)
NVDA   465.96 (+2.40%)
NIO   7.49 (-3.35%)
BABA   72.33 (+1.17%)
AMD   128.37 (+9.89%)
T   17.09 (+0.89%)
F   10.82 (+1.22%)
MU   73.65 (+0.71%)
CGC   0.72 (+3.57%)
GE   119.48 (-0.28%)
DIS   92.35 (+0.93%)
AMC   6.82 (+0.44%)
PFE   28.63 (-0.56%)
PYPL   58.48 (-1.76%)
XOM   98.42 (-0.70%)
S&P 500   4,585.59 (+0.80%)
DOW   36,117.38 (+0.17%)
QQQ   390.43 (+1.40%)
AAPL   194.27 (+1.01%)
MSFT   370.95 (+0.58%)
META   326.59 (+2.88%)
GOOGL   136.93 (+5.31%)
AMZN   146.88 (+1.63%)
TSLA   242.64 (+1.37%)
NVDA   465.96 (+2.40%)
NIO   7.49 (-3.35%)
BABA   72.33 (+1.17%)
AMD   128.37 (+9.89%)
T   17.09 (+0.89%)
F   10.82 (+1.22%)
MU   73.65 (+0.71%)
CGC   0.72 (+3.57%)
GE   119.48 (-0.28%)
DIS   92.35 (+0.93%)
AMC   6.82 (+0.44%)
PFE   28.63 (-0.56%)
PYPL   58.48 (-1.76%)
XOM   98.42 (-0.70%)
S&P 500   4,585.59 (+0.80%)
DOW   36,117.38 (+0.17%)
QQQ   390.43 (+1.40%)
AAPL   194.27 (+1.01%)
MSFT   370.95 (+0.58%)
META   326.59 (+2.88%)
GOOGL   136.93 (+5.31%)
AMZN   146.88 (+1.63%)
TSLA   242.64 (+1.37%)
NVDA   465.96 (+2.40%)
NIO   7.49 (-3.35%)
BABA   72.33 (+1.17%)
AMD   128.37 (+9.89%)
T   17.09 (+0.89%)
F   10.82 (+1.22%)
MU   73.65 (+0.71%)
CGC   0.72 (+3.57%)
GE   119.48 (-0.28%)
DIS   92.35 (+0.93%)
AMC   6.82 (+0.44%)
PFE   28.63 (-0.56%)
PYPL   58.48 (-1.76%)
XOM   98.42 (-0.70%)

TRACON Pharmaceuticals (TCON) Insider Trading & Ownership

$0.20
-0.01 (-3.85%)
(As of 04:29 PM ET)
Compare
Today's Range
$0.19
▼
$0.21
50-Day Range
$0.13
▼
$0.23
52-Week Range
$0.13
▼
$2.19
Volume
918,035 shs
Average Volume
1.37 million shs
Market Capitalization
$6.23 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$4.33
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media

TRACON Pharmaceuticals (NASDAQ:TCON) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
5.27%
Number Of
Insiders Buying
(Last 12 Months)
2
Amount Of
Insider Buying
(Last 12 Months)
$493,825.38
Number Of
Insiders Selling
(Last 12 Months)
0
Get TCON Insider Trade Alerts

Want to know when executives and insiders are buying or selling TRACON Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

TCON Insider Buying and Selling by Quarter


TRACON Pharmaceuticals Insider and Congressional Trades History

Export to Excel
Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
4/26/2023Charles TheuerCEOBuy3,999$0.66$2,639.34  
3/9/2023Opaleye Management Inc.Major ShareholderBuy174,508$1.38$240,821.04  
2/28/2023Charles TheuerCEOBuy200$1.52$304.00  
1/18/2023Charles TheuerCEOBuy6,800$1.62$11,016.00  
12/14/2022Charles TheuerCEOBuy23,000$1.29$29,670.00  
12/14/2022Opaleye Management Inc.Major ShareholderBuy167,500$1.25$209,375.00  
(Data available from 1/1/2013 forward)












TCON Insider Trading Activity - Frequently Asked Questions

Who is on TRACON Pharmaceuticals's Insider Roster?

The list of insiders at TRACON Pharmaceuticals includes Charles Theuer, Ikarian Capital, Llc, Mark C. Wiggins, Opaleye Management Inc., Saundra L Pelletier, Scott B Brown. Learn more on insiders at TCON.

What percentage of TRACON Pharmaceuticals stock is owned by insiders?

5.27% of TRACON Pharmaceuticals stock is owned by insiders. Learn more on TCON's insider holdings.

Which TRACON Pharmaceuticals insiders have been buying company stock?

The following insiders have purchased TCON shares in the last 24 months: Charles Theuer ($175,068.34), Opaleye Management Inc. ($2,486,382.88), and Scott B Brown ($7,870.00).

How much insider buying is happening at TRACON Pharmaceuticals?

Insiders have purchased a total of 1,692,158 TCON shares in the last 24 months for a total of $2,669,321.22 bought.

Which TRACON Pharmaceuticals insiders have been selling company stock?

The following insider sold TCON shares in the last 24 months: Opaleye Management Inc. ($2,216.16).

How much insider selling is happening at TRACON Pharmaceuticals?

Insiders have sold a total of 1,539 TRACON Pharmaceuticals shares in the last 24 months for a total of $2,216.16 sold.


More Insider Trading Tools from MarketBeat

Related Companies:
Insider Tracking Tools:
Insider Trading By Country:
Latest Articles:
This page (NASDAQ:TCON) was last updated on 12/7/2023 by MarketBeat.com Staff

My Account -